Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
May 25, 2021
A lot of recent discussions focus on how to expand COVID-19 vaccine manufacturing capacity in low- and middle-income countries (LMICs). The conversations highlight the importance of technology transfer and the capability of the tech transfer receiving sites (the facilities in these countries that wo...
Blog Post
May 24, 2021
After its first wave peaked in September 2020, India declared victory over COVID-19. With reported cases decreasing, vaccines on the horizon, and social restrictions lifted, life began returning to normal. But today, India’s health system is overwhelmed and a humanitarian crisis is unfolding. ...
Blog Post
April 13, 2021
Research findings are most impactful when considered a global public good, accessible by anyone, and, for publicly funded research, there is no reason why this should not be the case. The current research publishing system—dominated by a number of large for-profit publishers—is expensive and ineffec...
Blog Post
February 23, 2021
In 2020, epidemiological modelling went from relative obscurity to being central in helping governments, and the public, understand COVID-19 as it spread around the world. In 2021, with the emergence of effective COVID-19 vaccines, Health Technology Assessment (HTA) will be critical to making the be...